Which dosage of simvastatin in renal transplant patients?

被引：4

作者：

Çelik, A

Ünsal, A

Mutaf, I

Habif, S

Ok, E

Bayindir, O

机构：

[1] Ege Univ, Sch Med, Dept Nephrol, Izmir, Turkey

[2] Ege Univ, Sch Med, Dept Biochem, Izmir, Turkey

来源：

NEPHRON | 2000年 / 84卷 / 01期

关键词：

D O I：

10.1159/000045544

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：81 / 82

页数：2

共 9 条

[1]

ARNODOTTIR M, 1993, NEPHRON, V65, P410

[2]

HERNANDEZ BEM, 1993, NEPHROL DIAL TRANSPL, V8, P637

[3]

HOLDAAS H, 1995, AM J CARDIOL, V76, pA102

[4] POSTTRANSPLANT HYPERLIPIDEMIA - THE TREATMENT DILEMMA [J].

HRICIK, DE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (05) :766-771

[5]

KANDUS A, 1994, TRANSPLANT P, V26, P2642

[6]

KOBASHIGAWA JA, 1990, CIRCULATION, V82, P281

[7] LOVASTATIN THERAPY FOR HYPERCHOLESTEROLEMIA IN CARDIAC TRANSPLANT RECIPIENTS [J].

KUO, PC ;

KIRSHENBAUM, JM ;

GORDON, J ;

LAFFEL, G ;

YOUNG, P ;

DISESA, VJ ;

MUDGE, GH ;

VAUGHAN, DE .

AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (10) :631-635

[8] IS MYOPATHY IN RENAL-TRANSPLANT PATIENTS INDUCED BY CYCLOSPORINE OR COLCHICINE [J].

RUMPF, KW ;

HENNING, HV .

LANCET, 1990, 335 (8692) :800-801

[9]

YOSHIMURA N, 1994, TRANSPLANT P, V26, P2632

← 1 →